Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Oncolym: Began Clinical Trial

Techniclone Corp. (TCLN), Tustin, Calif.
Product: Oncolym
Business: Cancer
Therapeutic category: Antibody,

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE